Synapse - Brian Kushner

Results (51)

Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression

Journal Article

Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma

Meeting Abstract

Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
Cancer Research (2020)

Fulltext@MSK | Save

Focal nodular hyperplasia in survivors of childhood cancer

Meeting Abstract

Considine, C.; Do, K. G.; Moskowitz, C.; Tonorezos, E.; Behr, G.; Diotallevi, D.; Candela, J.; Kushner, B.; Wexler, L.; Boulad, F.; more...
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma

Journal Article

Stone, A.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Wu, X.; Cheung, N. K.; Sklar, C. A.
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

Humanized 3F8 anti-G(D2) monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma: A phase 1 clinical trial

Journal Article

Kushner, B. H.; Cheung, I. Y.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K.
JAMA Oncology (2018)

Fulltext@MSK | Save

Assessment of late pulmonary outcomes and exercise capacity among pediatric survivors of high-risk neuroblastoma

Meeting Abstract

Stone, A. E.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Veler, H.; Wu, X.; Cheung, N.; more...
American Journal of Respiratory and Critical Care Medicine (2018)

Fulltext@MSK | Save

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Journal Article

Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
OncoImmunology (2018)

Fulltext@MSK | Save

Germline BRCA2 mutations detected in pediatric sequencing studies impact parents' evaluation and care

Journal Article

Walsh, M. F.; Kennedy, J.; Harlan, M.; Kentsis, A.; Shukla, N.; Musinsky, J.; Roberts, S.; Kung, A. L.; Robson, M.; Kushner, B. H.; more...
Cold Spring Harbor Molecular Case Studies (2017)

Fulltext@MSK | Save

MYCN-amplified stage 2/3 neuroblastoma: Excellent survival in the era of anti-G(D2) immunotherapy

Journal Article

Kushner, B. H.; LaQuaglia, M. P.; Modak, S.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Yataghene, K.; Cheung, I. Y.; Cheung, N. V.
Oncotarget (2017)

Fulltext@MSK | Save

Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival

Journal Article

Cheung, I. Y.; Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
OncoImmunology (2017)

Fulltext@MSK | Save